Model N Holder ClearBridge Says Vista Equity Deal Undervalues Company
NeuroSense Collaborates With Lonza To Identify Exosome-Based Biomarkers For Advance Neurodegenerative Disease Treatments And Diagnostics
NeuroSense will leverage its extensive experience in biomarker utilization to advance early diagnosis and treatment in the neurodegeneration fieldLonza to develop, optimize, and qualify a method utili
ClearBridge Energy Midstream Opportunity Fund Raises Dividend by 3.1% to $0.67
ClearBridge Energy MLP Total Return Fund Declares $0.70 Dividend
ClearBridge MLP and Midstream Fund Reports NAV per Share of $44.3
Franklin Clearbridge Sustainable Global Infrastructure Income Fund Declares CAD 0.0217 Dividend